Medicare Enrolled

Dr. Jihad Mustapha, M.D.

Cardiovascular Disease · Punta Gorda, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
310 NESBIT ST, Punta Gorda, FL 33950
9415598995
In practice since 2005 (20 years)
NPI: 1316938723 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mustapha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mustapha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mustapha

Dr. Jihad Mustapha is a cardiovascular disease in Punta Gorda, FL, with 20 years in practice. Based on federal Medicare data, Dr. Mustapha performed 792 Medicare services across 389 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mustapha received a total of $1,786,370 from 44 pharmaceutical and/or device companies across 700 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mustapha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 792 Medicare services$ $1,786,370 industry payments

Medicare Practice Summary

Medicare Utilization ↗
792
Medicare services
Bottom 21% in FL for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
389
Unique beneficiaries
$662
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes343$8$25
Ultrasonic guidance for blood vessel access108$30$90
Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel82$131$405
Ultrasound evaluation of blood vessel with review by radiologist, initial vessel73$718$2,181
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes70$38$115
Removal of plaque in artery of leg, initial vessel43$6,387$20,364
Removal of plaque in arteries of leg40$4,110$20,022
Balloon dilation of artery of leg, each additional vessel19$625$1,898
Review by radiologist of abdominal aorta image14$98$298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,786,370
Total received (2018-2024)
Avg $255,196/year across 7 years
Top 0% in FL for cardiovascular disease
44
Companies
700
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$649,828 (36.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$431,237 (24.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$353,719 (19.8%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$317,075 (17.7%)
Scientific / Research
Research funding and grants
$25,195 (1.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,316 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$151,379
2023
$95,551
2022
$311,287
2021
$689,082
2020
$78,790
2019
$180,514
2018
$279,767

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bard Peripheral Vascular, Inc.
$694,186
ASAHI INTECC CO., LTD.
$312,505
Cardiovascular Systems Inc.
$195,732
Cardio Flow, Inc.
$100,490
Terumo Medical Corporation
$86,758
Medtronic Vascular, Inc.
$64,185
Corindus Inc.
$59,787
AngioDynamics, Inc.
$48,717
Philips Electronics North America Corporation
$42,840
ASAHI INTECC USA, INC.
$32,656
BARD PERIPHERAL VASCULAR, INC.
$27,022
Boston Scientific Corporation
$26,249
BOSTON SCIENTIFIC CORPORATION
$25,592
LimFlow Inc.
$12,082
CORDIS US CORP.
$11,314
Bayer HealthCare Pharmaceuticals Inc.
$11,200
Avinger Inc.
$10,638
Medtronic, Inc.
$7,598
Abbott Laboratories
$5,907
Siemens Medical Solutions USA, Inc.
$5,750
Reflow Medical Inc
$2,154
Cagent Vascular LLC
$638
Surmodics, Inc.
$500
Cook Medical LLC
$500
Lutonix, Inc.
$248
ShockWave Medical, Inc
$230
Philips North America LLC
$128
Janssen Pharmaceuticals, Inc
$106
HyperMed Imaging Inc.
$79
Ra Medical Systems, Inc.
$63
Veryan Medical Incorporated
$60
Organogenesis Inc.
$60
Integra LifeSciences Corporation
$54
PFIZER INC.
$53
BIOTRONIK INC.
$44
Kiniksa Pharmaceuticals, Ltd.
$44
Cardinal Health 200, LLC
$42
TRUVIC MEDICAL, INC.
$37
Maquet Cardiovascular U.S. Sales, L.L.C.
$32
Amgen Inc.
$22
Smith+Nephew, Inc.
$21
Transit Scientific, LLC
$20
Novartis Pharmaceuticals Corporation
$12
Shockwave Medical, Inc
$12
Top 3 companies account for 67.3% of total payments
Associated products mentioned in payments ›
(0888) PV 018 OTW · (4067) Tack Endovascular Systems BTK · (6346) Intrasight Mobile · (6391) Nexcimer · (6582) Visions 035 · (7881) Ultrasound Und · (9270) Lasers · (9281) Turbo Elite · (9285) AngioSculpt PV · (9520) IGT Devices Und · (9520) IGT Devices Undivided · (9547) IGT Systems Und · (P84) IGT Devices Systems · (V061) IVUS Systems · ABRE · ASAHI PTCA Guide Wire · ASAHI PTCA Guide Wire ASAHI Gladius Mongo 14 · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AngioSeal · Arcalyst · Auryon Laser System 100-120 Vac · BRITE TIP · BRITE TIP RADIANZ · BioMimics · CLINICAL TRIAL PRODUCT · CROSSER · Chocolate PTA Balloon · Clinical Trial Product · CorPath GRX · Coronary Orbital Atherectomy System · DABRA · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · ELUVIA · ENTRESTO · EVLT · Ellipsys · Endurant · FLIXENE · FlowMet-R · GENERAL VASCULAR INTERVENTION · GENERAL - ATHERECTOMY · GENERAL - THERAPIES · GENERAL - VASCULAR INTERVENTION · GENERAL GUIDEWIRES · GENERAL METALLIC STENTS · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GLIDESHEATH SLENDER · GLIDEWIRE · GRAFIX PL · General - Non-Vascular Intervention · GlideWire · Glidesheath · HawkOne · Heartrail · HyperView Hyperspectral Tissue Oxygenation Measurement System · IGT D Peripheral · IGT Devices Und · IGT_D Peripheral · IN.PACT ADMIRAL · IN.PACT Admiral · INFINITI · IVUS Systems · Image Guided Therapy Devices _ Peripheral · JETSTREAM · JOT DX · LIFESTREAM · LIMFLOW SYSTEM · LUTONIX · LUTONIX Drug Coated Balloon · Lasers · MetaCross · Misago · Mynx Venous VCD · MynxGrip Vascular Closure Device · NAVICROSS · NEONT · Navicross · OMNIGRAFT · Omnilink Elite vascular stent system · OptiCross 35 · PANTHERIS · PERIPHERAL GUIDEWIRE · PERIPHERAL VASCULAR · PRIMATRIX · Peripheral Orbital Atherectomy System · Puraply · QT Vascular Chocolate PTA Balloon · RADIAL 360 · RADIANZ · RAIN SHEATH · RAIN SHEATH TRANSRADIAL · Ranger · Repatha · S.M.A.R.T. · SAVION · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Spectranetics Undiv · Sublime 014 Rx PTA Balloon Dilatation Catheter · Supera peripheral stent system · THERAPIES · TR Band · TURBOHAWK · Trilogy 100 · TurboHawk · VENACURE 1470 PRO · VENOVO · VYNDAQEL · Varithena Administration Pack · Vascular Lithotripsy · VenaSeal · XARELTO · Xarelto
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 0% for cardiovascular disease in FL.

Equivalent to $225,552 per 100 Medicare services performed
Looking for a cardiovascular disease in Punta Gorda?
Compare cardiovascular diseases in the Punta Gorda area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
39
Per 100K population
20.0
County median income
$66,154
Nearest hospital
SHOREPOINT HEALTH PUNTA GORDA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mustapha is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 0%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mustapha experienced with use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes?
Based on Medicare claims data, Dr. Mustapha performed 343 use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mustapha receive payments from pharmaceutical companies?
Yes. Dr. Mustapha received a total of $1,786,370 from 44 companies across 700 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mustapha's costs compare to other cardiovascular diseases in Punta Gorda?
Dr. Mustapha's average Medicare payment per service is $662. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mustapha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →